Skip to content
Recall Observatory FDA recall evidence

Drug product

Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heights, NJ 07922. Carton NDC# 0641-6048-25, Vial NDC# 0641-6048-01

D-1309-2022

July 11, 2022

Class II

Product summary

Firm
Hikma Pharmaceuticals USA Inc.
Event
Event 90583
Status
Terminated
Classification
Class II
Quantity
713,550 vials
Official record key
drug-enforcement:D-1309-2022

Official wording

Reason: Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.

Code information: Lot # 070088, exp. date 07/2023

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out-of-specification